FDA Approval Activities for this Drug…

Alrex (Loteprednol Etabonate) Ophthalmic Suspension, 0.2% Bausch and Lomb NDA 20803 Lotemax (Loteprednol Etabonate), 0.5% Bausch and Lomb NDA 20-841 3/9/98 3/9/98 6/25/98 4/11/02 Lotemax (Loteprednol Etabonate), Ophthalmic Suspension, 0.5% Pharmos NDA 20-583 | Zylet (loteprednol etabonate and tobramycin) ophthalmic suspension, Bausch & Lomb, Approval

For the latest approval information, please locate this drug using this index.